Pharmacovigilance – News and Features

Funds to advance development of Creabilis’ first-in-class products.

Canadian health care system more effectively implement new practices and speed improvements in patient care.

Population Diagnostics, Inc. announces the appointment of Sir Walter Bodmer, one of the world’s preeminent human geneticists, to its Scientific Advisory Board.

Enrollment of phase I/II trial for CYT387 complete.

A team of researchers from Roche have generated the first draft genome sequence of the cynomolgus monkey and developed a novel microarray design for in depth expression profiling for use in preclinical drug safety research.

The collaboration will develop a chip to screen for safe and effective drugs far more swiftly and efficiently than current methods, and before they are tested in humans.

Expanding advanced cancer diagnostic and molecular imaging capabilities.

VistaGen provides comprehensive update on the Company's strategic plan to develop and commercialize its technology platform and lead small molecule CNS drug candidate.

Resminostat shows substantial clinical benefit in heavily pre-treated relapsed/refractory HL patients.

The study shows that an intravenously-delivered viral therapy can consistently infect and spread within tumours without harming normal tissues in humans.